Doxorubicin (generic), Adriamycin, Doxil News

Halozyme Therapeutics, Inc. , a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the presentation of positive pre-clinical animal efficacy ...

Halozyme Therapeutics, Inc. , a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the presentation of positive pre-clinical animal efficacy ...

Over years or decades, a proportion of people with chronic hepatitis B or C virus infection will develop hepatocellular carcinoma , or primary liver cancer.

Halozyme Therapeutics, Inc. , a biopharmaceutical company developing and commercializing products targeting the extracellular matrix, today announced the presentation of positive pre-clinical animal efficacy ...

A method that could be applied widely to explore genetic basis of cancer drug resistance Why do cancer patients develop resistance to chemotherapy drugs, sometimes abruptly, after a period in which the drugs ...

Why do cancer patients develop resistance to chemotherapy drugs, sometimes abruptly, after a period in which the drugs seem to be working well to reduce tumors or hold them in check? Although largely a mystery ...

BioAlliance Pharma SA , the specialty pharmaceutical company focused on the treatment of opportunistic infections in cancer and HIV, announced today the suspension of its Phase II trial of doxorubicin Transdrug ...

Washington, July 15: Scientists at Washington University in St. Louis say that they have moved a step closer to delivering cancer-killing medicines to paediatric brain tumours.

Patients who receive treatment for Kaposi's sarcoma consisting of pegylated liposomal doxorubicin with potent antiretroviral therapy have a low rate of relapse, according to a retrospective Spanish study ...

A new treatment strategy using targeted nanoparticles to block metastasis with anti-cancer drugs leads to good results using significantly lower doses of toxic chemotherapy, with less collateral damage to ...

The phenomenon of co-localization of transcriptionally upregulated genes showing similar expression levels is known across all eukaryotic genomes.

By using tumor-targeting nanoparticles filled with chemotherapy drugs, scientists kept kidney and pancreas cancers from spreading through the bodies of mice.

Clear guidelines are lacking on the assessment of lymphatic dissemination and on the anatomic extent of this assessment Women undergoing lymphatic assessment for endometrial cancer should undergo full ...

Participating patients will receive several rounds of targeted chemotherapy using the drugs cisplatin and doxorubicin via surgically implanted catheters.

Tumor Biology Center, Breisacher Straβe 117, 79106 Freiburg, Federal Republic of Germany, Department of Physiology and Pharmacology, Sackler School of Medicine, Tel-Aviv University, Tel-Aviv 69978, ...

Arch Dermatol. 2008;144 :720. Prospective Multicenter Study of Pegylated Liposomal Doxorubicin Treatment in Patients With Advanced or Refractory Mycosis Fungoides or Szary Syndrome Cutaneous T-cell lymphomas ...

Main Category: Cancer / Oncology Also Included In: Biology / Biochemistry ; Clinical Trials / Drug Trials ; Breast Cancer Article Date: 11 Jun 2008 - 6:00 PDT Novel Targeted Therapy Reduces Chemoresistance in ...

A novel small molecule inhibitor reduced both endogenous and drug-induced resistance to chemotherapy in a mouse model of melanoma.

Micro- and nanoparticles are considered suitable drug delivery systems for their unique features, such as a large surface to volume ratio, and for the possibility to tune their size and hydrophobicity.

Madison, Wis. - A few weeks ago, in this column , I wrote that folks at Madison-based Quintessence Bioscience eagerly anticipated the outcome of a Phase IIIb clinical trial that Alfacell Corp.